FindTrial
Sign In

Extraperitoneal bupivacaine following TEP

Extraperitoneal bupivacaine following TEP hernia repair , proscective randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160711001
Enrollment
Unknown
Registered
2016-07-11
Start date
2016-04-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

reducible unilateral inguinal hernia inguinal hernia

Interventions

installation 0.25% bupivacaine 40 ml in pre peritoneal space before mesh placement after The Totally Extraperitoneal Hernia Repair ,installation normal saline 40 ml in pre peritoneal space before mesh
Experimental Drug,Placebo Comparator Other
bupivacaine group,control

Sponsors

Hatyai hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 70 Years

Inclusion criteria

Inclusion criteria: age more than 13 yeras old ASA class 1-2

Exclusion criteria

Exclusion criteria: ASA class3-5 pregnancy risk to general anes thesia or laparoscopy allergy to bupivacaine deny to randomized for study

Design outcomes

Primary

MeasureTime frame
post operative pain 3days numberic rating scale and visual analog scale—

Secondary

MeasureTime frame
complicaion 30days All complication—

Countries

Thailand

Contacts

Public ContactChusaeng Teerawiwatchai

Hatyai hospital

schusaeng@gmail.com066 0816909902

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026